Şahin Kaan Baydemir

Dr. Şahin Kaan Baydemir

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in JBRA Assisted Reproduction
Verified
Journal Article
Open access
ŞBŞahin Kaan Baydemir
Şahin Kaan Baydemir
YSYavuz Emre Sukur
Yavuz Emre Sukur
NENur Ersan
Nur Ersan
ODOzlem Dogan
Ozlem Dogan
CACem Somer Atabekoglu
Cem Somer Atabekoglu
Objective: To compare cord-blood anti-Mullerian hormone levels between female newborns from women with and without polycystic ovary syndrome. Methods: A prospective case-control study was conducted in Ankara University School of Medicine, Department of Obstetrics and Gynecology between June 2020 and January 2021. In total, 408 women gave birth to a female during the study period. Of those, 45 had a polycystic ovary syndrome-like history. We did not find the preconceptional history of 16 women. Two women were excluded due to other endocrine disorders. The polycystic ovary syndrome group consisted of 27 women with polycystic ovary syndrome that gave birth to a female newborn during the study period and the non-polycystic ovary syndrome control group consisted of 33 women who had regular cycles prior to pregnancy, were never diagnosed with polycystic ovary syndrome, and gave birth to female newborns. The primary outcome measure was the cord-blood anti-Mullerian hormone levels. Results: The median cord-blood anti-Mullerian hormone levels of female newborns from polycystic ovary syndrome patients were significantly higher than those in the non-polycystic ovary syndrome group (0.33ng/ml vs. 0.12ng/ml, respectively; p<0.001). In addition, cord blood anti-Mullerian hormone levels were significantly higher in both obese and non-obese polycystic ovary syndrome patients when compared to body-mass-index-matched non- polycystic ovary syndrome patients (0.37ng/ml vs. 0.06ng/ml, respectively; p=0.013 and 0.30ng/ml vs. 0.11 ng/ml, respectively; p=0.003). Conclusions: The cord blood anti-Mullerian hormone levels were higher in female newborns of women with polycystic ovary syndrome when compared to non-polycystic ovary syndrome controls. The effect of polycystic ovary syndrome seems to be greater than body mass index on cord blood anti-Mullerian hormone levels.

12 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BTBatuhan Turgay
Batuhan Turgay
UZUğurcan Zorlu
Uğurcan Zorlu
BVBulut Varlı
Bulut Varlı
GYgülşah aynaoğlu yıldız
gülşah aynaoğlu yıldız
ŞBŞahin Kaan Baydemir
Şahin Kaan Baydemir
TTTahsin Murat Turgay
Tahsin Murat Turgay
Objective: This study aims to evaluate obstetric and neonatal outcomes in pregnancies complicated by RDs and to identify hemogram-derived biomarkers associated with adverse perinatal events. Methods: This retrospective cohort study analyzed 360 pregnancies in individuals diagnosed with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), ankylosing spondylitis (AS), Sjögren’s disease, sarcoidosis, undifferentiated connective tissue disease (UCTD), and other autoimmune conditions, followed up at the Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine, between 2013 and 2018. Data on disease activity, maternal complications, neonatal outcomes, and inflammatory markers were extracted from electronic medical records. Results: Patients with SSc had the highest rates of preterm birth (57.1%) and fetal growth restriction (FGR) (42.9%), whereas those with SLE (50%) and AS (25%) exhibited the highest disease flare rates. Neonates born to mothers with SSc, SLE, and Sjögren’s disease had significantly lower Apgar scores, suggesting increased neonatal distress. NICU admission was associated with elevated neutrophil-to-lymphocyte ratio (NLR) and eosinophil-to-lymphocyte ratio (ELR), with higher NLR and ELR also predicting spontaneous abortion. Monocyte-to-lymphocyte ratio (MLR) and ELR demonstrated the highest predictive value for composite adverse perinatal outcomes. Additionally, RA patients experiencing disease flares had an 87.5% cesarean section (CS) rate, significantly exceeding the general population rate. Conclusions: This study underscores the increased risk of preterm birth, FGR, and neonatal complications in RD pregnancies, particularly in SSc and SLE patients. The findings suggest that early risk assessment using hemogram-based inflammatory markers may improve perinatal management and patient stratification.

8 April 2026 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
ÖCÖzgün Ceylan
Özgün Ceylan
SCSinem Ceylan
Sinem Ceylan
ŞBŞahin Kaan Baydemir
Şahin Kaan Baydemir
GGGülten Güvenç
Gülten Güvenç
VKVakkas Korkmaz
Vakkas Korkmaz

28 April 2026 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
OKOğuz Kaan Köksal
Oğuz Kaan Köksal
ŞBŞahin Kaan Baydemir
Şahin Kaan Baydemir
HÖHande Nur Nur Öncü
Hande Nur Nur Öncü
FBFatma Ecem Bakan
Fatma Ecem Bakan
NÖNeslihan Öztürk
Neslihan Öztürk
VKVakkas Korkmaz
Vakkas Korkmaz

25 June 2020 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Verified
Journal Article
Closed access
BVBulut Varlı
Bulut Varlı
ŞBŞahin Kaan Baydemir
Şahin Kaan Baydemir
YŞYavuz Emre Şükür
Yavuz Emre Şükür
BBBülent Berker
Bülent Berker
Amaç: Laparoskopik myomektomi sırasında belirgin hemorajiye neden olarak postoperatif hemoglobin düşüşüne etki eden faktörlerin belirlenmesi Gereç ve Yöntem: Tersiyer merkezde 5 yıllık süre boyunca laparoskopik myomektomi operasyonu geçiren ve hastane bilgi yönetimi sistemine verileri eksiksiz girilmiş hastaların dosyaları retrospektif olarak incelendi. Çalışmaya toplam 152 hasta dahil edildi. Tüm hastalardan postoperatif 8. saatte hemogram kontrolü yapıldı. Preoperatif hemoglobin değerinin 2 g/dL azalması belirgin hemoraji olarak kabul edildi. Vaka grubu 38, kontrol grubu 114 hasta içermekteydi. Gruplar; toplam myom boyutu, dominant myom boyutu, 1’den fazla myom varlığı gibi intraoperatif hemorajiye neden olabilecek faktörler açısından karşılaştırıldı. Bulgular: Dominant myom boyutunun 6 cm’den büyük olması ve 1’den fazla sayıda myomun çıkarılması postoperatif belirgin hemoglobin düşüşüne neden olsa da hastanede kalış süresi bu durumdan olumsuz olarak etkilenmemektedir. Sonuç: Laparoskopik myomektomi öncesi her hasta mutlaka görüntüleme yöntemleriyle değerlendirilmeli ve myomlar haritalandırılarak cerrahi yaklaşım buna göre belirlenmelidir. Çok sayıda myom varlığı veya dominant myomun büyük olduğu durumlarda hastalar ameliyat öncesi dönemde transfüzyon ihtiyacı ve laparotomiye dönüş hakkında bilgilendirilmeli, intraoperatif hemostaz konusunda dikkatli olunmalıdır.

29 October 2023 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
BVBulut Varlı
Bulut Varlı
ŞBŞahin Kaan Baydemir
Şahin Kaan Baydemir
YŞYavuz Emre Şükür
Yavuz Emre Şükür
BBBülent Berker
Bülent Berker
Aims: The excision of myomas is commonly carried out in symptomatic women who choose to preserve their uterus, either using an open or minimally invasive (hysteroscopy, laparoscopy, robotic) approach. Patient selection is a critical factor in achieving a successful laparoscopic myomectomy. Prior abdominal surgery was not defined as a risk factor, however, the safest approach in these cases is still the subject of intense debate The aim of this study was to evaluate the safety of laparoscopic myomectomy in patients with previous abdominal surgery. Methods: A retrospective cohort study was conducted on the files and operative notes of the patients who underwent laparoscopic myomectomy operation in a university-hospital based gynaecology department between January 2012 and March 2017. The patients were classified into two groups; Group 1 consisted of 34 patients who had previously undergone abdominal surgery, whereas the Group 2 comprised 118 patients who had not undergone any abdominal surgery. Results: There were no significant difference between patients with and without a history of abdominal surgery in terms of operation time, postoperative hospital stays, blood loss, rate of operative complications, or conversion rate to open surgery. Conclusion: A history of abdominal surgery seems to have no negative impact on the safety of a subsequent laparoscopic myomectomy.